Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |